Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT-Reference-Cited by-同舟云学术

Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT

Published:2018-10-25 Issue:7 Volume:54 Page:1022-1028
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Moiseev Ivan S.^ORCID,Tsvetkova Tatyana,Aljurf Mahmoud,Alnounou Randa M,Bogardt Janet,Chalandon Yves,Drokov Mikhail Yu.^ORCID,Dvirnyk Valentina,Faraci Maura^ORCID,Friis Lone Smidstrup,Giglio Fabio,Greinix Hildegard T.,Kornblit Brian Thomas,Koelper Christiane,Koenecke Christian^ORCID,Lewandowski Krzysztof,Niederwieser Dietger^ORCID,Passweg Jakob R.,Peczynski Christophe,Penack Olaf,Peric Zinaida,Piekarska Agnieszka,Ronchi Paola Erminia,Rovo Alicia,Rzepecki Piotr,Scuderi Francesca,Sigrist Daniel,Siitonen Sanna M.,Stoelzel Friedrich,Sulek Kazimierz,Tsakiris Dimitrios A.,Wilkowojska Urszula,Duarte Rafael F,Ruutu Tapani,Basak Grzegorz W^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0374-3.pdf

Reference24 articles.

1. Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009;4:345–53.

2. Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124:645–53.

3. Gloude NJ, Khandelwal P, Luebbering N, Lounder DT, Jodele S, Alder MN, et al. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. Blood. 2017;130:1259–66.

4. Mulay S, Kreuter JD, Bryant SC, Elliott MA, Hogan WJ, Winters JL, et al. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant. J Clin Apher. 2015 ;30:147–53.

5. de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, et al. Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC. Transplantation. 2015;99:1953–9.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of the Consensus Definition of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Requires a More Expansive Lens to Accurately Diagnose and Risk Stratify Patients—Beware Reliance on Schistocytes Alone;Transplantation and Cellular Therapy;2024-08

2. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research;Transplantation and Cellular Therapy;2023-03

3. Epidemiology and outcomes of pediatric transplant‐associated thrombotic microangiopathy in Hong Kong;Pediatric Transplantation;2022-07-21

4. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?;Transplantation and Cellular Therapy;2022-07

5. Snakebite Associated Thrombotic Microangiopathy and Recommendations for Clinical Practice;Toxins;2022-01-14